Skip to main content
Fig. 5 | Cancer Cell International

Fig. 5

From: Systematic profiling of alternative splicing in Helicobacter pylori-negative gastric cancer and their clinical significance

Fig. 5

Two nomograms and corresponding results showed the prognostic value of AS events and clinicopathologic data. Nomogram for predicting OS (a) and DFS (d) in the HP− GC cohort. Calibration plot of the AS-clinicopathologic nomogram in terms of the agreement between nomogram-predicted and observed 1-, 2-, and 3-years OS (b) and DFS (e) in the HP− GC cohort. c, f Decision curve analysis of the AS-clinicopathologic nomogram for 1-, 2-, and 3-years risk in the HP− GC cohort. AS alternative splicing, OS overall survival, DFS disease-free survival, HP−GC Helicobacter pylori-negative gastric cancer, ROC receiver operating characteristic

Back to article page